Genenta Science

GNTA

Market cap $31.8M

0.6602 USD

-0.0618

8.56%

At close Updated Oct 14, 4:00 PM EDT

Pre-market

After hours

0.6550

-0.0052

0.79%

1 day

-8.56%

5 days

-11.99%

1 month

-20.59%

3 months

-47.18%

6 months

2.96%

Year to date

-53.18%

1 year

-79.11%

5 years

-94%

10 years

-94%

About: Genenta Science SPA is an industrial consolidator focused on acquiring majority or full ownership of privately held, established companies operating in Italian national-security-regulated sectors. Its acquisition activities span aerospace, defense, national security (including cybersecurity), and biotechnology/biosecurity, with a focus on businesses covered by Italy's Golden Power legislation.

Employees: 9

Industrials Conglomerates

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit

The Spring Assembly manufactured by Sòphia HT, a strategic Genenta investment, supports the separation of the launcher's second and third stages Sòphia HT has been in serial production of the component since 2018 MILAN, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A.

Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit

Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm

MILAN and NAPLES, Italy, July 23, 2026 (GLOBE NEWSWIRE) -- Sòphia High Tech S.r.l. (Sòphia HT), an Italian aerospace and defense company manufacturing critical parts for Europe's space and defense programs, backed by Genenta Science S.p.A.

Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm

Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results

Fiscal Year 2025 Highlights FY2025 sales rose 29.3% to €7.17 million; total value of production increased 34.7% to €8.47 million EBITDA grew 68.1% to €1.61 million, expanding the EBITDA margin by approximately 380 basis points to 19.0% Operating profit advanced 80.8% to €1.21 million MILAN, July 22, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on aerospace, defense, biotech and Italian national-security-related technologies, today announced that the Board of Directors of Sòphia High Tech S.r.l.

Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results

Genenta signs Definitive Agreements with Sophia High Tech

Genenta signs Definitive Agreements with Sophia High Tech Genenta enters aerospace as it continues its strategic transformation into a next-generation ind

Genenta signs Definitive Agreements with Sophia High Tech

Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs

MILAN, March 27, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian national-security-related technologies, today announced that it has entered into a binding offer with Sòphia High Tech S.r.l.

Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs

Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini

Focused on selective acquisitions of high-quality companies in strategic industrial sectors Focused on selective acquisitions of high-quality companies in strategic industrial sectors

Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini

Genenta, Evolving into Saentra Forge, Announces CEO's Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University

MILAN, March 13, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) transforming to Saentra Forge (Nasdaq: SAEN)1, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian national-security-related technologies, today announced that Pierluigi Paracchi, CEO of the Company, has been appointed as a member of the Board of Guarantors of the Italian Academy for Advanced Studies in America, the prestigious center for advanced scholarship hosted at Columbia University in New York, dedicated to promoting Italian culture, research, and intellectual exchange between Italy and the United States.

Genenta, Evolving into Saentra Forge, Announces CEO's Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University

Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform

MILAN, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) in transformation to Saentra Forge (Nasdaq: SAEN), a strategic industrial consolidator focused on biotech, defense, aerospace, and national-security-related technologies, today announced the appointment of Paolo Salvato to the Board of Directors of ATC, a manufacturer of tactical defense systems representing the Company's initial entry into defense technology manufacturing.

Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform

Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investments

Genenta Science S.p.A. (NASDAQ: GNTA) on Tuesday said it is transitioning to a next-generation strategic industrial consolidator, focusing on acquiring privately held businesses in national-security regulated sectors.

Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investments

Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator

Building on Biotech Heritage, Expanding into Defense and National Security Through Industrial Integrations of Privately Held Specialized Italian Companies ATC - a Defense-Sector Company: First Industrial Integration Praexidia Foundation Joins as a Long-Term Strategic Shareholder Corporate Name Change to Saentra Forge S.p.A. Biotech Clinical Updates and Partnering Strategy Cash, Cash Equivalents, and Marketable Securities of approx.

Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator

See News Rankings

Price charts implemented using Lightweight Charts™